Inactive Instrument

diaDexus, Inc. Share Price OTC Bulletin Board

Pharmaceuticals

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

17/21/17	Diadexus, Inc. Went Out of Business	CI
08/18/08	Motion for Asset Sale Approved for Diadexus, Inc.	CI

on all subscriptions*

Exceptional extension!

Enjoy this offer

* See conditions under "Our services"

Diadexus, Inc. is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of patients throughout the course of cardiac disease. Its capabilities include manufacturing, assay development, Food and Drug Administration (FDA) regulatory clearance, and marketing and selling products. Its commercially-available products consist of two FDA-cleared tests to measure Lp-PLA2: the PLAC Test ELISA Kit (the PLAC ELISA Test) and the PLAC Test for Lp-PLA2 Activity (the PLAC Activity Test). Its other products include proADM; proET-1, which aids in predication of heart failure, and proANP, which aids in predication of heart failure. The Company sells its diagnostic products to laboratories and promotes these products to the laboratories' sales representatives, as well as directly to healthcare providers.

Employees

Sector

Pharmaceuticals

More about the company

Market Cap	49.2T 43.22T 39.83T 37.28T 69.85T 46.61L 71.03T 5L 2L 22.87L 2L 2L 79.48L	P/E 2014	-3.26x	P/E 2015	-1.14x
Enterprise Value	52.9L 46.47L 42.82L 40.09L 75.11L 50Cr 76.37L 5.14Cr 1.99Cr 25Cr 1.99Cr 1.94Cr 85Cr	EV / Sales 2014	1.05x	EV / Sales 2015	0.77x
Free-Float	100%	Yield 2014 *	-	Yield 2015	-

17/21/17	Diadexus, Inc. Went Out of Business	CI
08/18/08	Motion for Asset Sale Approved for Diadexus, Inc.	CI
09/18/09	Motion for Asset Sale Filed by Diadexus, Inc.	CI
01/16/01	Diazyme Laboratories, Inc. completed the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	CI
29/16/29	Motion for Asset Sale Approved for Diadexus, Inc.	CI
29/16/29	General Atomics Corp. entered into purchase agreement to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $4.8 million.	CI
20/16/20	Cleveland HeartLab, Inc. cancelled the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	CI
07/16/07	Motion for Asset Sale Filed by Diadexus, Inc.	CI
07/16/07	Cleveland HeartLab, Inc. agreed to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $7 million.	CI
13/16/13	Diadexus, Inc. Filed for Bankruptcy	CI
10/16/10	Diadexus, Inc. Announces Resignation of Leone Patterson as Chief Financial Office	CI
23/16/23	Diadexus, Sonic Healthcare USA Sign National Agreement for PLAC Activity Test	CI
30/16/30	Diadexus, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2016	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ULTRAGENYX PHARMACEUTICAL INC.	-0.43%	+16.10%	-21.67%	-42.53%	285.04Cr
SAREPTA THERAPEUTICS, INC.	-1.02%	+10.99%	-7.18%	-84.65%	186.34Cr
BIONOTE, INC.	-4.68%	-11.71%	-15.38%	-4.27%	30Cr
DK LIFE SCIENCE CO., LTD.	-5.05%	-13.31%	-45.02%	-	5.56Cr
Average	-2.81%	+2.47%	-22.31%	-43.81%	126.79Cr
Weighted average by Cap.	-0.97%	+13.66%	-16.23%	-55.87%

	2014	2015
Net sales	2.61Cr 2.29Cr 2.11Cr 1.98Cr 3.71Cr 247.36Cr 3.77Cr 25Cr 9.82Cr 121.37Cr 9.8Cr 9.59Cr 421.82Cr	1.79Cr 1.57Cr 1.45Cr 1.36Cr 2.54Cr 169.41Cr 2.58Cr 17Cr 6.73Cr 83Cr 6.71Cr 6.57Cr 288.9Cr
Net income	-84.67L -74.38L -68.54L -64.16L -1.2Cr -80Cr -1.22Cr -8.23Cr -3.19Cr -39Cr -3.18Cr -3.11Cr -136.78Cr	-71.66L -62.95L -58.01L -54.3L -1.02Cr -68Cr -1.03Cr -6.97Cr -2.7Cr -33Cr -2.69Cr -2.63Cr -115.76Cr
Net Debt	-2L -2L -2L -2L -3L -1.88Cr -3L -19.25L -7L -92.03L -7L -7L -3.2Cr	52.41L 46.04L 42.43L 39.72L 74.41L 50Cr 75.66L 5.09Cr 1.97Cr 24Cr 1.97Cr 1.93Cr 85Cr

diaDexus, Inc. Share Price OTC Bulletin Board

Stocks

Pharmaceuticals

Valuation: diaDexus, Inc.

Latest news : diaDexus, Inc.

Diagnostic & Testing Substances Manufacturers

Financials

Company Profile